APA (7th ed.) Citation

DD, A., MS, S., LM, S., S, D., CL, S., CM, K., . . . DL, W. (2020). Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation. The Journal of infectious diseases, 222(8), 1334. https://doi.org/10.1093/infdis/jiaa254

Chicago Style (17th ed.) Citation

DD, Anthony, et al. "Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation." The Journal of Infectious Diseases 222, no. 8 (2020): 1334. https://doi.org/10.1093/infdis/jiaa254.

MLA (9th ed.) Citation

DD, Anthony, et al. "Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation." The Journal of Infectious Diseases, vol. 222, no. 8, 2020, p. 1334, https://doi.org/10.1093/infdis/jiaa254.